260 related articles for article (PubMed ID: 20063867)
1. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems.
Tan A; Simovic S; Davey AK; Rades T; Boyd BJ; Prestidge CA
Mol Pharm; 2010 Apr; 7(2):522-32. PubMed ID: 20063867
[TBL] [Abstract][Full Text] [Related]
2. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
[TBL] [Abstract][Full Text] [Related]
3. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
[TBL] [Abstract][Full Text] [Related]
4. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles.
Simovic S; Hui H; Song Y; Davey AK; Rades T; Prestidge CA
J Control Release; 2010 May; 143(3):367-73. PubMed ID: 20079390
[TBL] [Abstract][Full Text] [Related]
5. Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro performance.
Lim LH; Tan A; Simovic S; Prestidge CA
Int J Pharm; 2011 May; 409(1-2):297-306. PubMed ID: 21371543
[TBL] [Abstract][Full Text] [Related]
6. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Yasmin R; Tan A; Bremmell KE; Prestidge CA
J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
[TBL] [Abstract][Full Text] [Related]
7. Hybrid lipid-silica microcapsules engineered by phase coacervation of Pickering emulsions to enhance lipid hydrolysis.
Simovic S; Heard P; Prestidge CA
Phys Chem Chem Phys; 2010 Jul; 12(26):7162-70. PubMed ID: 20490395
[TBL] [Abstract][Full Text] [Related]
8. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
[TBL] [Abstract][Full Text] [Related]
9. The role of porous nanostructure in controlling lipase-mediated digestion of lipid loaded into silica particles.
Joyce P; Tan A; Whitby CP; Prestidge CA
Langmuir; 2014 Mar; 30(10):2779-88. PubMed ID: 24552363
[TBL] [Abstract][Full Text] [Related]
10. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
Dening TJ; Rao S; Thomas N; Prestidge CA
Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
[TBL] [Abstract][Full Text] [Related]
11. Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
Rao S; Tan A; Boyd BJ; Prestidge CA
Nanomedicine (Lond); 2014 Dec; 9(18):2745-59. PubMed ID: 24938439
[TBL] [Abstract][Full Text] [Related]
12. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
Fatouros DG; Bergenstahl B; Mullertz A
Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
[TBL] [Abstract][Full Text] [Related]
13. Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation.
Nguyen TH; Tan A; Santos L; Ngo D; Edwards GA; Porter CJ; Prestidge CA; Boyd BJ
J Control Release; 2013 Apr; 167(1):85-91. PubMed ID: 23353808
[TBL] [Abstract][Full Text] [Related]
14. Tableting lipid-based formulations for oral drug delivery: a case study with silica nanoparticle-lipid-mannitol hybrid microparticles.
Bremmell KE; Tan A; Martin A; Prestidge CA
J Pharm Sci; 2013 Feb; 102(2):684-93. PubMed ID: 23242712
[TBL] [Abstract][Full Text] [Related]
15. Controlling the enzymatic digestion of lipids using hybrid nanostructured materials.
Tan A; Colliat-Dangus P; Whitby CP; Prestidge CA
ACS Appl Mater Interfaces; 2014 Sep; 6(17):15363-71. PubMed ID: 25116477
[TBL] [Abstract][Full Text] [Related]
16. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
Tan A; Davey AK; Prestidge CA
Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
[TBL] [Abstract][Full Text] [Related]
17. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
18. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
19. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
Simovic S; Barnes TJ; Tan A; Prestidge CA
Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
[TBL] [Abstract][Full Text] [Related]
20. Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs.
Yasmin R; Rao S; Bremmell K; Prestidge C
Eur J Pharm Sci; 2017 Jan; 96():508-514. PubMed ID: 27793717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
